Le Lézard
Classified in: Science and technology
Subjects: Conference, Trade Show, Award

Phillips-Medisize Wins "Best Connected Health Platform" Designation in 2019 MedTech Breakthrough Awards Program

Phillips-Medisize, a Molex company, today announced that MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, has selected its Connected Health Platform (CHP) as the winner of its "Best Overall Connected Healthcare Solution" award in the 2019 MedTech Breakthrough Awards program.

Incorporating more than a decade of experience in developing connected health solutions, the Phillips-Medisize CHP encompasses extensive information-sharing, analytics capabilities, robust cybersecurity and streamlined regulatory documentation to support medical device, pharmaceutical and diagnostics companies.

"We extend a hearty congratulations to the Phillips-Medisize team on their success and innovation in the connected health space and are proud to recognize them as a marquee 2019 MedTech Breakthrough Award winner," said James Johnson, managing director, MedTech Breakthrough. "Their cloud-based CHP helps pharmaceutical companies and drug delivery device developers tackle the worldwide challenge of patient medication adherence, while speeding development time to market and keeping healthcare costs down."

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Robotics, Clinical Administration, Telehealth, Patient Engagement, Electronic Health Records (EHR), mHealth, Medical Devices, Medical Data and many more. This year's program attracted more than 3,500 nominations from over 15 different countries throughout the world.

"We thank the MedTech Breakthrough organization for taking the time and effort to acknowledge Phillips-Medisize for our CHP solution," said Matt Jennings, CEO and President of Phillips-Medisize. "We're honored to receive this award as a testament that our global team of experts continues to deliver innovative ideas to help transform the diagnosis and delivery of healthcare."

The award-winning Connected Health Platform (CHP) is registered with the FDA as a Medical Device Data System (MDDS) and is designed from the ground up to support patients with their medication regimes and related data. The system includes simple, intuitive mobile apps and reminders to support and motivate users.

Phillips-Medisize's CHP can track medication usage for multiple drug products, on a global basis, in real-time. The CHP comes with a Software Development Toolkit (SDK) and defined, extensible API, allowing any device to be connected to the system. This enables pharmaceutical companies to deploy a single solution across all therapy areas and drug compounds if desired, instead of having to utilize different companies' platforms for each product and device type.

Pharmaceutical companies and payer/provider organizations also benefit from the platform's powerful analytics package, which is designed to connect and display information from connected drug delivery devices, biosensors and regulated Mobile Medical Applications (SaMD/MMA). This enables customers to quickly generate views of their data and create data presentation layers for use by the analytics engine, providing deep insight into how medication is taken.

Additionally, with the Phillips-Medisize CHP being built on InterSystem's HealthShare technology, the solution benefits from the interoperability ingrained within this technology. This allows the CHP to integrate healthcare data from multiple sources via its enterprise master patient index. The data can be made actionable for payers and providers, allowing connection, via integration, to various EMR and EHR systems.

MD&M East attendees have the opportunity to see the CHP and other Phillips-Medisize medical device solutions at Booth 1615 at the Jacob K. Javits Convention Center in New York, New York ? June 11 ? 13, 2019.

About Phillips-Medisize:

Phillips-Medisize, a Molex company, is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, medical device and specialty commercial market segments. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize's core advantage is the knowledge of its people to integrate design, molding, electronics, and automation, providing innovative, high-quality manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com.

About MedTech Breakthrough:

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

These press releases may also interest you

at 10:45
TopConsumerReviews.com recently gave its best-in-class 5 star rating to Limos, a leader among Limo Services. The reasons for riding a limousine are endless. Whether it's just a trip from the airport, or fancy transportation to a girls' night or Prom,...

at 10:44
The best businesses in 33 European countries have been recognised in a 'Ones to Watch' list of business excellence published today by the European Business Awards, one of the world's largest and longest running cross sector businesses competitions....

at 10:36
According to Coherent Market Insights, the global testing, inspection, and certification (TIC) market is projected to exhibit a CAGR of 5.9% over the forecast period (2019 ? 2027). Market growth opportunities in the Global Testing, Inspection, and...

at 10:35
High incidence of chronic diseases globally and the need for personalized medicine, has encouraged several technological advancements in the form of recombinant DNA that involves genetic combinations of species to treat diseases. The recombinant DNA...

at 10:35
Tata & Howard, Inc. is pleased to announce Conner Bogle and Thatcher Schechtman as the recipients of the 2019 Donald J. Tata Engineering Scholarship. The Donald J. Tata Engineering Scholarship was established in 2017 to honor the late Don Tata,...

at 10:30
Raytheon today signed a Memorandum of Understanding with the UK Ministry of Defence to join Team ARTEMIS Industry, a collaboration between government and industry formed to fast track the launch of a small satellite constellation and enhance the...

News published on 5 june 2019 at 12:05 and distributed by: